Global Left-atrial Appendage Occlusion (LAAO) Device 麻豆原创 Growth (Status and Outlook) 2025-2031

Publication ID:

LPI04254336

Publication Date:

April 23, 2025

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global Left-atrial Appendage Occlusion (LAAO) Device market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
LAAO devices are implanted in the heart and are intended to reduce the risk of thromboembolism from the left atrial appendage (LAA) in patients with non-valvular atrial fibrillation. The device mechanically occludes the LAA to prevent LAA thrombus from entering the systemic circulation.
United States market for Left-atrial Appendage Occlusion (LAAO) Device is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Left-atrial Appendage Occlusion (LAAO) Device is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Left-atrial Appendage Occlusion (LAAO) Device is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Left-atrial Appendage Occlusion (LAAO) Device players cover Boston Scientific Corp, AtriCure, Abbott, Biosense Webster, Lifetech Scientific, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The 鈥淟eft-atrial Appendage Occlusion (LAAO) Device Industry Forecast鈥� looks at past sales and reviews total world Left-atrial Appendage Occlusion (LAAO) Device sales in 2024, providing a comprehensive analysis by region and market sector of projected Left-atrial Appendage Occlusion (LAAO) Device sales for 2025 through 2031. With Left-atrial Appendage Occlusion (LAAO) Device sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Left-atrial Appendage Occlusion (LAAO) Device industry.
This Insight Report provides a comprehensive analysis of the global Left-atrial Appendage Occlusion (LAAO) Device landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Left-atrial Appendage Occlusion (LAAO) Device portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Left-atrial Appendage Occlusion (LAAO) Device market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Left-atrial Appendage Occlusion (LAAO) Device and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Left-atrial Appendage Occlusion (LAAO) Device.
This report presents a comprehensive overview, market shares, and growth opportunities of Left-atrial Appendage Occlusion (LAAO) Device market by product type, application, key players and key regions and countries.
Segmentation by Type:
Endocardial
Epicardial
Others
Segmentation by Application:
Hospitals
Outpatient Surgery Center
Heart Clinic
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Boston Scientific Corp
AtriCure
Abbott
Biosense Webster
Lifetech Scientific
Append Medical

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Left-atrial Appendage Occlusion (LAAO) Device 麻豆原创 Size (2020-2031)
2.1.2 Left-atrial Appendage Occlusion (LAAO) Device 麻豆原创 Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Left-atrial Appendage Occlusion (LAAO) Device by Country/Region (2020, 2024 & 2031)
2.2 Left-atrial Appendage Occlusion (LAAO) Device Segment by Type
2.2.1 Endocardial
2.2.2 Epicardial
2.2.3 Others
2.3 Left-atrial Appendage Occlusion (LAAO) Device 麻豆原创 Size by Type
2.3.1 Left-atrial Appendage Occlusion (LAAO) Device 麻豆原创 Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Left-atrial Appendage Occlusion (LAAO) Device 麻豆原创 Size 麻豆原创 Share by Type (2020-2025)
2.4 Left-atrial Appendage Occlusion (LAAO) Device Segment by Application
2.4.1 Hospitals
2.4.2 Outpatient Surgery Center
2.4.3 Heart Clinic
2.4.4 Others
2.5 Left-atrial Appendage Occlusion (LAAO) Device 麻豆原创 Size by Application
2.5.1 Left-atrial Appendage Occlusion (LAAO) Device 麻豆原创 Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Left-atrial Appendage Occlusion (LAAO) Device 麻豆原创 Size 麻豆原创 Share by Application (2020-2025)
3 Left-atrial Appendage Occlusion (LAAO) Device 麻豆原创 Size by Player
3.1 Left-atrial Appendage Occlusion (LAAO) Device 麻豆原创 Size 麻豆原创 Share by Player
3.1.1 Global Left-atrial Appendage Occlusion (LAAO) Device Revenue by Player (2020-2025)
3.1.2 Global Left-atrial Appendage Occlusion (LAAO) Device Revenue 麻豆原创 Share by Player (2020-2025)
3.2 Global Left-atrial Appendage Occlusion (LAAO) Device Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Left-atrial Appendage Occlusion (LAAO) Device by Region
4.1 Left-atrial Appendage Occlusion (LAAO) Device 麻豆原创 Size by Region (2020-2025)
4.2 Global Left-atrial Appendage Occlusion (LAAO) Device Annual Revenue by Country/Region (2020-2025)
4.3 Americas Left-atrial Appendage Occlusion (LAAO) Device 麻豆原创 Size Growth (2020-2025)
4.4 APAC Left-atrial Appendage Occlusion (LAAO) Device 麻豆原创 Size Growth (2020-2025)
4.5 Europe Left-atrial Appendage Occlusion (LAAO) Device 麻豆原创 Size Growth (2020-2025)
4.6 Middle East & Africa Left-atrial Appendage Occlusion (LAAO) Device 麻豆原创 Size Growth (2020-2025)
5 Americas
5.1 Americas Left-atrial Appendage Occlusion (LAAO) Device 麻豆原创 Size by Country (2020-2025)
5.2 Americas Left-atrial Appendage Occlusion (LAAO) Device 麻豆原创 Size by Type (2020-2025)
5.3 Americas Left-atrial Appendage Occlusion (LAAO) Device 麻豆原创 Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Left-atrial Appendage Occlusion (LAAO) Device 麻豆原创 Size by Region (2020-2025)
6.2 APAC Left-atrial Appendage Occlusion (LAAO) Device 麻豆原创 Size by Type (2020-2025)
6.3 APAC Left-atrial Appendage Occlusion (LAAO) Device 麻豆原创 Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Left-atrial Appendage Occlusion (LAAO) Device 麻豆原创 Size by Country (2020-2025)
7.2 Europe Left-atrial Appendage Occlusion (LAAO) Device 麻豆原创 Size by Type (2020-2025)
7.3 Europe Left-atrial Appendage Occlusion (LAAO) Device 麻豆原创 Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Left-atrial Appendage Occlusion (LAAO) Device by Region (2020-2025)
8.2 Middle East & Africa Left-atrial Appendage Occlusion (LAAO) Device 麻豆原创 Size by Type (2020-2025)
8.3 Middle East & Africa Left-atrial Appendage Occlusion (LAAO) Device 麻豆原创 Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Left-atrial Appendage Occlusion (LAAO) Device 麻豆原创 Forecast
10.1 Global Left-atrial Appendage Occlusion (LAAO) Device Forecast by Region (2026-2031)
10.1.1 Global Left-atrial Appendage Occlusion (LAAO) Device Forecast by Region (2026-2031)
10.1.2 Americas Left-atrial Appendage Occlusion (LAAO) Device Forecast
10.1.3 APAC Left-atrial Appendage Occlusion (LAAO) Device Forecast
10.1.4 Europe Left-atrial Appendage Occlusion (LAAO) Device Forecast
10.1.5 Middle East & Africa Left-atrial Appendage Occlusion (LAAO) Device Forecast
10.2 Americas Left-atrial Appendage Occlusion (LAAO) Device Forecast by Country (2026-2031)
10.2.1 United States 麻豆原创 Left-atrial Appendage Occlusion (LAAO) Device Forecast
10.2.2 Canada 麻豆原创 Left-atrial Appendage Occlusion (LAAO) Device Forecast
10.2.3 Mexico 麻豆原创 Left-atrial Appendage Occlusion (LAAO) Device Forecast
10.2.4 Brazil 麻豆原创 Left-atrial Appendage Occlusion (LAAO) Device Forecast
10.3 APAC Left-atrial Appendage Occlusion (LAAO) Device Forecast by Region (2026-2031)
10.3.1 China Left-atrial Appendage Occlusion (LAAO) Device 麻豆原创 Forecast
10.3.2 Japan 麻豆原创 Left-atrial Appendage Occlusion (LAAO) Device Forecast
10.3.3 Korea 麻豆原创 Left-atrial Appendage Occlusion (LAAO) Device Forecast
10.3.4 Southeast Asia 麻豆原创 Left-atrial Appendage Occlusion (LAAO) Device Forecast
10.3.5 India 麻豆原创 Left-atrial Appendage Occlusion (LAAO) Device Forecast
10.3.6 Australia 麻豆原创 Left-atrial Appendage Occlusion (LAAO) Device Forecast
10.4 Europe Left-atrial Appendage Occlusion (LAAO) Device Forecast by Country (2026-2031)
10.4.1 Germany 麻豆原创 Left-atrial Appendage Occlusion (LAAO) Device Forecast
10.4.2 France 麻豆原创 Left-atrial Appendage Occlusion (LAAO) Device Forecast
10.4.3 UK 麻豆原创 Left-atrial Appendage Occlusion (LAAO) Device Forecast
10.4.4 Italy 麻豆原创 Left-atrial Appendage Occlusion (LAAO) Device Forecast
10.4.5 Russia 麻豆原创 Left-atrial Appendage Occlusion (LAAO) Device Forecast
10.5 Middle East & Africa Left-atrial Appendage Occlusion (LAAO) Device Forecast by Region (2026-2031)
10.5.1 Egypt 麻豆原创 Left-atrial Appendage Occlusion (LAAO) Device Forecast
10.5.2 South Africa 麻豆原创 Left-atrial Appendage Occlusion (LAAO) Device Forecast
10.5.3 Israel 麻豆原创 Left-atrial Appendage Occlusion (LAAO) Device Forecast
10.5.4 Turkey 麻豆原创 Left-atrial Appendage Occlusion (LAAO) Device Forecast
10.6 Global Left-atrial Appendage Occlusion (LAAO) Device Forecast by Type (2026-2031)
10.7 Global Left-atrial Appendage Occlusion (LAAO) Device Forecast by Application (2026-2031)
10.7.1 GCC Countries 麻豆原创 Left-atrial Appendage Occlusion (LAAO) Device Forecast
11 Key Players Analysis
11.1 Boston Scientific Corp
11.1.1 Boston Scientific Corp Company Information
11.1.2 Boston Scientific Corp Left-atrial Appendage Occlusion (LAAO) Device Product Offered
11.1.3 Boston Scientific Corp Left-atrial Appendage Occlusion (LAAO) Device Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.1.4 Boston Scientific Corp Main Business Overview
11.1.5 Boston Scientific Corp Latest Developments
11.2 AtriCure
11.2.1 AtriCure Company Information
11.2.2 AtriCure Left-atrial Appendage Occlusion (LAAO) Device Product Offered
11.2.3 AtriCure Left-atrial Appendage Occlusion (LAAO) Device Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.2.4 AtriCure Main Business Overview
11.2.5 AtriCure Latest Developments
11.3 Abbott
11.3.1 Abbott Company Information
11.3.2 Abbott Left-atrial Appendage Occlusion (LAAO) Device Product Offered
11.3.3 Abbott Left-atrial Appendage Occlusion (LAAO) Device Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.3.4 Abbott Main Business Overview
11.3.5 Abbott Latest Developments
11.4 Biosense Webster
11.4.1 Biosense Webster Company Information
11.4.2 Biosense Webster Left-atrial Appendage Occlusion (LAAO) Device Product Offered
11.4.3 Biosense Webster Left-atrial Appendage Occlusion (LAAO) Device Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.4.4 Biosense Webster Main Business Overview
11.4.5 Biosense Webster Latest Developments
11.5 Lifetech Scientific
11.5.1 Lifetech Scientific Company Information
11.5.2 Lifetech Scientific Left-atrial Appendage Occlusion (LAAO) Device Product Offered
11.5.3 Lifetech Scientific Left-atrial Appendage Occlusion (LAAO) Device Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.5.4 Lifetech Scientific Main Business Overview
11.5.5 Lifetech Scientific Latest Developments
11.6 Append Medical
11.6.1 Append Medical Company Information
11.6.2 Append Medical Left-atrial Appendage Occlusion (LAAO) Device Product Offered
11.6.3 Append Medical Left-atrial Appendage Occlusion (LAAO) Device Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.6.4 Append Medical Main Business Overview
11.6.5 Append Medical Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.